Prostate Cancer Clinical Trials in Georgia

Showing 121-140 of 317 trials

LTFU for All Cell and Gene Therapy Studies

NCT06194461

Master LTFU study will monitor the long-term safety and tolerability of cell or gene therapy study participants from AstraZeneca for up to 15 years post last cell or gene therapy treatment.

Hepatocellular CarcinomaProstate Cancer

AstraZeneca64 participantsStarted Sep 2025

Phoenix, Arizona, United States • Duarte, California, United States • Orange, California, United States +22 more locations

COMPLETEDPhase 365 miles

A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer

NCT04100018

The purpose of this study is to assess the safety and effectiveness of nivolumab with docetaxel in men with advanced castration resistant prostate cancer who have progressed after second-generation hormonal manipulation.

Prostate Cancer

Bristol-Myers Squibb1,030 participantsStarted Feb 2020

Mobile, Alabama, United States • Anchorage, Alaska, United States • Tucson, Arizona, United States +290 more locations

LTFU for All Cell and Gene Therapy Studies

A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer

Prostate Cancer Trials in Other Cities

Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)

Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer

Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)

Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy

Other Conditions in Georgia